 |
| CLICK HERE TO VIEW CURRENT ISSUE |
 |
| Best of NAMA 2026 |
|
 |
|
KEY GLYPHOSATE COURT TRIAL BEGINS THIS WEEK
Feb. 25, 2019
POLITICO reports:
A high-stakes federal trial begins in California today involving a man diagnosed with non-Hodgkin lymphoma who is seeking compensation from Bayer because he claims its weedkiller Roundup caused his cancer. Roundup was developed by Monsanto, which merged with Bayer last year.
Edwin Hardeman's case is the first to head to trial as part of a multidistrict litigation involving more than 1,600 plaintiffs, and it's expected to set the tone for the other cancer patients' cases.
Bayer insists that Roundup is safe. Both sides will call scientific experts to the stand who will offer competing views about the health and safety of Monsanto's glyphosate-based products.
The Roundup case, as well as the Ninth Circuit's rehearing of a challenge to EPA's chlorpyrifos ban walkback, will test what role courts will play in deciding what products consumers and farmers can apply to their lawns and fields.
|
|
|
|
|
